canada generic semaglutide in Just Got More Affordable Canada approves generic semaglutide from

As of 2026, Mounjaro (tirzepatide) is an established once-weekly injection in the UK for adults with obesity, or overweight with a weight-related comorbidity, used alongside a reduced-calorie diet and increased physical activity

tirzepatide activates both GLP-1 and GIP receptors, a dual mechanism that produces greater average weight loss in clinical trials

Understanding whether these medications directly cause gallbladder problemsor whether rapid weight loss drives the associationis essential for patients and clinicians making treatment decisions

Common side effects include nausea, vomiting, diarrhea, constipation and abdominal pain, as well as headache and dizziness

Prescription weight loss injections may be incorporated into a medical weight loss program in Florida when ordered by a licensed provider and dispensed through a licensed pharmacy